NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

11332	Companies
251872	Keywords
181148	Articles
137669	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 06/04/2024 at 12:30, 2 years 5 months ago

The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
NanoViricides, Inc. reports positive pharmacokinetic profile of NV-387 in non-human primate model, showcasing sustained blood concentrations enabling less frequent dosing for its broad-spectrum antiviral agent. The unique polymeric design supports potential against RSV, COVID, and influenza

NV-387 NanoViricides Inc. Broad-spectrum Antiviral Agent Pharmacokinetic Profile RSV COVID Influenza
BRIEF

published on 05/29/2024 at 12:35, 2 years 5 months ago

NanoViricides Unveils Revolutionary Broad-Spectrum Antiviral Agent

NV-387 Clinical Trials Antiviral Nanomedicine Broad-spectrum
BRIEF

published on 05/29/2024 at 12:35, 2 years 5 months ago

NanoViricides dévoile un agent antiviral révolutionnaire à large spectre

NV-387 Essais Cliniques Antiviral Nanomédecine À Large Spectre
PRESS RELEASE

published on 05/29/2024 at 12:30, 2 years 5 months ago

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
NanoViricides, Inc. elaborates on its groundbreaking host-mimetic, broad-spectrum antiviral technology platform, NV-387, designed to revolutionize viral infection treatment with advanced decoy mechanisms

NV-387 NanoViricides Inc. Broad-spectrum Host-mimetic Technology Antiviral Agent
BRIEF

published on 05/23/2024 at 12:35, 2 years 5 months ago

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.

NanoViricides NV-387 Partnership Antiviral Aagami
BRIEF

published on 05/23/2024 at 12:35, 2 years 5 months ago

NanoViricides renforce les efforts de partenariat - engage Aagami Inc.

NanoViricides NV-387 Partenariat Antiviral Aagami
PRESS RELEASE

published on 05/23/2024 at 12:30, 2 years 5 months ago

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
NanoViricides, Inc. engages Aagami, Inc. to seek licensing and partnering opportunities for its antiviral nanomedicines including key asset NV-387. Aagami to focus on India and Japan

NV-387 NanoViricides Inc. Antiviral Nanomedicines Aagami Inc. Licensing And Partnering Opportunities
BRIEF

published on 05/20/2024 at 12:35, 2 years 5 months ago

NV-387 Shows Promising Results in Treating Lethal RSV Infection in Animal Study

NanoViricides NV-387 Clinical Trials Antiviral RSV
BRIEF

published on 05/20/2024 at 12:35, 2 years 5 months ago

Le NV-387 montre des résultats prometteurs dans le traitement de l'infection mortelle par le VRS dans une étude animale

NanoViricides NV-387 Essais Cliniques Antiviral VRS
PRESS RELEASE

published on 05/20/2024 at 12:30, 2 years 5 months ago

Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection

NV-387 Clinical Trials NanoViricides Inc. Antiviral RSV

Accesswire

Published on 11/13/2026 at 02:40, 6 hours 23 minutes ago

Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 6 hours 53 minutes ago

Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 9 hours 38 minutes ago

Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 9 hours 58 minutes ago

Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 10 hours 3 minutes ago

Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening

View all ACCESSWIRE

EQS Group

Published on 11/13/2026 at 08:30, 32 minutes ago

Dahua Pro Challenge 2026 Celebrates Global Installer Expertise and Long-term Collaboration
Published on 11/13/2026 at 08:30, 33 minutes ago

Softing AG: Interim Statement on the 3rd Quarter and First 9 Months of 2026
Published on 11/13/2026 at 08:00, 1 hour 3 minutes ago

Uzin Utz SE has published its third-quarter financial results: an increase in sales and stable earnings performance despite subdued momentum in the construction sector due to ongoing market headwinds
Published on 11/13/2026 at 08:00, 1 hour 3 minutes ago

Cairn Homes Plc: Transaction in Own Shares
Published on 11/13/2026 at 07:48, 1 hour 14 minutes ago

Nagarro releases unaudited Q3 2026 results, posts 2.7% constant currency growth for 9 months ended September 2026

Les Echos

Published on 11/13/2026 at 08:00, 1 hour 3 minutes ago

Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 9 hours 50 minutes ago

Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 9 hours 50 minutes ago

Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 10 hours 3 minutes ago

Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 14 hours 26 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026

View all LES ECHOS COMFI WIRE